COVID-19 Impact on Global Recombinant Human Insulin Market Insights, Forecast to 2026
- BMR3871646
- 113 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human Insulin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human Insulin industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human Insulin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human Insulin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human Insulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human Insulin market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Recombinant Human Insulin market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Recombinant Human Insulin market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Human Insulin market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Human Insulin market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human Insulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human Insulin market.
The following manufacturers are covered in this report:
Akron Biotech
Wockhardt
Dance Biopharm
Novo Nordisk
Gan & Lee
United Laboratories
Dongbro Pharmaceuticri
...
Recombinant Human Insulin Breakdown Data by Type
by Recombinant DNA Technology Using Fermentation in Bacteria Way
by Recombinant DNA Technology Using Fermentation in Yeast Way
Recombinant Human Insulin Breakdown Data by Application
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Licenses Type
USD 3,900 Single License
USD 7,800 Enterprise License
BUY NOW Add to Cart
Why QYR
Fastest report delivery service
More than 10 years of vast experience
Operational for 24 * 7 & 365 days
In-depth and comprehensive analysis
Excellent after sales support
Owns large database
Need Help ?
Email Us FAQ
COVID 19 Impact on Global Recombinant Human Insulin market
1.1 Recombinant Human Insulin Product Introduction
1.2 Market Segments
1.3 Key Recombinant Human Insulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Human Insulin Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Recombinant Human Insulin Market Size Growth Rate by Application
1.5.2 Type 1 Diabetes Mellitus
1.5.3 Type 2 Diabetes Mellitus
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human Insulin Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human Insulin Industry
1.6.1.1 Recombinant Human Insulin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human Insulin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human Insulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Insulin Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Insulin Revenue 2015-2026
2.1.2 Global Recombinant Human Insulin Sales 2015-2026
2.2 Recombinant Human Insulin Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Human Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Human Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Human Insulin Competitor Landscape by Players
3.1 Recombinant Human Insulin Sales by Manufacturers
3.1.1 Recombinant Human Insulin Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Human Insulin Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Human Insulin Revenue by Manufacturers
3.2.1 Recombinant Human Insulin Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Human Insulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Human Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2019
3.2.5 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Human Insulin Price by Manufacturers
3.4 Recombinant Human Insulin Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Insulin Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Insulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Human Insulin Market Size by Type (2015-2020)
4.1.1 Global Recombinant Human Insulin Sales by Type (2015-2020)
4.1.2 Global Recombinant Human Insulin Revenue by Type (2015-2020)
4.1.3 Recombinant Human Insulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Human Insulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Human Insulin Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Insulin Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Human Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Human Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Human Insulin Market Size by Application (2015-2020)
5.1.1 Global Recombinant Human Insulin Sales by Application (2015-2020)
5.1.2 Global Recombinant Human Insulin Revenue by Application (2015-2020)
5.1.3 Recombinant Human Insulin Price by Application (2015-2020)
5.2 Recombinant Human Insulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Human Insulin Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Insulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Insulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Human Insulin by Country
6.1.1 North America Recombinant Human Insulin Sales by Country
6.1.2 North America Recombinant Human Insulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Human Insulin Market Facts & Figures by Type
6.3 North America Recombinant Human Insulin Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Human Insulin by Country
7.1.1 Europe Recombinant Human Insulin Sales by Country
7.1.2 Europe Recombinant Human Insulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Insulin Market Facts & Figures by Type
7.3 Europe Recombinant Human Insulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Insulin by Region
8.1.1 Asia Pacific Recombinant Human Insulin Sales by Region
8.1.2 Asia Pacific Recombinant Human Insulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Human Insulin Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Human Insulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Human Insulin by Country
9.1.1 Latin America Recombinant Human Insulin Sales by Country
9.1.2 Latin America Recombinant Human Insulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Human Insulin Market Facts & Figures by Type
9.3 Central & South America Recombinant Human Insulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Insulin by Country
10.1.1 Middle East and Africa Recombinant Human Insulin Sales by Country
10.1.2 Middle East and Africa Recombinant Human Insulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Human Insulin Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Human Insulin Market Facts & Figures by Application
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Corporation Information
11.1.2 Akron Biotech Description, Business Overview and Total Revenue
11.1.3 Akron Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akron Biotech Recombinant Human Insulin Products Offered
11.1.5 Akron Biotech Recent Development
11.2 Wockhardt
11.2.1 Wockhardt Corporation Information
11.2.2 Wockhardt Description, Business Overview and Total Revenue
11.2.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Wockhardt Recombinant Human Insulin Products Offered
11.2.5 Wockhardt Recent Development
11.3 Dance Biopharm
11.3.1 Dance Biopharm Corporation Information
11.3.2 Dance Biopharm Description, Business Overview and Total Revenue
11.3.3 Dance Biopharm Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Dance Biopharm Recombinant Human Insulin Products Offered
11.3.5 Dance Biopharm Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Description, Business Overview and Total Revenue
11.4.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novo Nordisk Recombinant Human Insulin Products Offered
11.4.5 Novo Nordisk Recent Development
11.5 Gan & Lee
11.5.1 Gan & Lee Corporation Information
11.5.2 Gan & Lee Description, Business Overview and Total Revenue
11.5.3 Gan & Lee Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gan & Lee Recombinant Human Insulin Products Offered
11.5.5 Gan & Lee Recent Development
11.6 United Laboratories
11.6.1 United Laboratories Corporation Information
11.6.2 United Laboratories Description, Business Overview and Total Revenue
11.6.3 United Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 United Laboratories Recombinant Human Insulin Products Offered
11.6.5 United Laboratories Recent Development
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Corporation Information
11.7.2 Dongbro Pharmaceuticri Description, Business Overview and Total Revenue
11.7.3 Dongbro Pharmaceuticri Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Products Offered
11.7.5 Dongbro Pharmaceuticri Recent Development
11.1 Akron Biotech
11.1.1 Akron Biotech Corporation Information
11.1.2 Akron Biotech Description, Business Overview and Total Revenue
11.1.3 Akron Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akron Biotech Recombinant Human Insulin Products Offered
11.1.5 Akron Biotech Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Human Insulin Market Estimates and Projections by Region
12.1.1 Global Recombinant Human Insulin Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Human Insulin Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Human Insulin Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Human Insulin Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Human Insulin Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Human Insulin Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Human Insulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Human Insulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Human Insulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Human Insulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Human Insulin Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Human Insulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Human Insulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Human Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Human Insulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Recombinant Human Insulin Market Segments
Table 2. Ranking of Global Top Recombinant Human Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Human Insulin Market Size Growth Rate by Type 2020-2026 (g) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Recombinant Human Insulin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Recombinant Human Insulin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Recombinant Human Insulin Players to Combat Covid-19 Impact
Table 11. Global Recombinant Human Insulin Market Size Growth Rate by Application 2020-2026 (g)
Table 12. Global Recombinant Human Insulin Market Size by Region (g) & (US$ Million): 2020 VS 2026
Table 13. Global Recombinant Human Insulin Sales by Regions 2015-2020 (g)
Table 14. Global Recombinant Human Insulin Sales Market Share by Regions (2015-2020)
Table 15. Global Recombinant Human Insulin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Recombinant Human Insulin Sales by Manufacturers (2015-2020) (g)
Table 17. Global Recombinant Human Insulin Sales Share by Manufacturers (2015-2020)
Table 18. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Insulin as of 2019)
Table 20. Recombinant Human Insulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Recombinant Human Insulin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Recombinant Human Insulin Price (2015-2020) (USD/mg)
Table 23. Recombinant Human Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Recombinant Human Insulin Product Type
Table 25. Date of International Manufacturers Enter into Recombinant Human Insulin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 28. Global Recombinant Human Insulin Sales Share by Type (2015-2020)
Table 29. Global Recombinant Human Insulin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Recombinant Human Insulin Revenue Share by Type (2015-2020)
Table 31. Recombinant Human Insulin Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 32. Global Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 33. Global Recombinant Human Insulin Sales Share by Application (2015-2020)
Table 34. North America Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 35. North America Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 36. North America Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 38. North America Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 39. North America Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 40. North America Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 41. North America Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 42. Europe Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 43. Europe Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 44. Europe Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 46. Europe Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 47. Europe Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 48. Europe Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 49. Europe Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Recombinant Human Insulin Sales by Region (2015-2020) (g)
Table 51. Asia Pacific Recombinant Human Insulin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Recombinant Human Insulin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Recombinant Human Insulin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 55. Asia Pacific Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 57. Asia Pacific Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 58. Latin America Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 59. Latin America Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 63. Latin America Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 64. Latin America Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 65. Latin America Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 67. Middle East and Africa Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 71. Middle East and Africa Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 73. Middle East and Africa Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 74. Akron Biotech Corporation Information
Table 75. Akron Biotech Description and Major Businesses
Table 76. Akron Biotech Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 77. Akron Biotech Product
Table 78. Akron Biotech Recent Development
Table 79. Wockhardt Corporation Information
Table 80. Wockhardt Description and Major Businesses
Table 81. Wockhardt Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 82. Wockhardt Product
Table 83. Wockhardt Recent Development
Table 84. Dance Biopharm Corporation Information
Table 85. Dance Biopharm Description and Major Businesses
Table 86. Dance Biopharm Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 87. Dance Biopharm Product
Table 88. Dance Biopharm Recent Development
Table 89. Novo Nordisk Corporation Information
Table 90. Novo Nordisk Description and Major Businesses
Table 91. Novo Nordisk Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 92. Novo Nordisk Product
Table 93. Novo Nordisk Recent Development
Table 94. Gan & Lee Corporation Information
Table 95. Gan & Lee Description and Major Businesses
Table 96. Gan & Lee Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 97. Gan & Lee Product
Table 98. Gan & Lee Recent Development
Table 99. United Laboratories Corporation Information
Table 100. United Laboratories Description and Major Businesses
Table 101. United Laboratories Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 102. United Laboratories Product
Table 103. United Laboratories Recent Development
Table 104. Dongbro Pharmaceuticri Corporation Information
Table 105. Dongbro Pharmaceuticri Description and Major Businesses
Table 106. Dongbro Pharmaceuticri Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 107. Dongbro Pharmaceuticri Product
Table 108. Dongbro Pharmaceuticri Recent Development
Table 109. Global Recombinant Human Insulin Sales Forecast by Regions (2021-2026) (g)
Table 110. Global Recombinant Human Insulin Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Recombinant Human Insulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Recombinant Human Insulin Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 114. North America: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 116. Europe: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Recombinant Human Insulin Sales Forecast by Region (2021-2026) (g)
Table 118. Asia Pacific: Recombinant Human Insulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 120. Latin America: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 122. Middle East and Africa: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Recombinant Human Insulin Players
Table 127. Recombinant Human Insulin Customers List
Table 128. Recombinant Human Insulin Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Human Insulin Sales Market Share by Application in 2020 & 2026
Figure 6. Type 1 Diabetes Mellitus
Figure 7. Type 2 Diabetes Mellitus
Figure 8. Recombinant Human Insulin Report Years Considered
Figure 9. Global Recombinant Human Insulin Market Size 2015-2026 (US$ Million)
Figure 10. Global Recombinant Human Insulin Sales 2015-2026 (g)
Figure 11. Global Recombinant Human Insulin Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Recombinant Human Insulin Sales Market Share by Region (2015-2020)
Figure 13. Global Recombinant Human Insulin Sales Market Share by Region in 2019
Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2015-2020)
Figure 15. Global Recombinant Human Insulin Revenue Market Share by Region in 2019
Figure 16. Global Recombinant Human Insulin Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human Insulin Revenue in 2019
Figure 18. Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Figure 20. Global Recombinant Human Insulin Sales Market Share by Type in 2019
Figure 21. Global Recombinant Human Insulin Revenue Market Share by Type (2015-2020)
Figure 22. Global Recombinant Human Insulin Revenue Market Share by Type in 2019
Figure 23. Global Recombinant Human Insulin Market Share by Price Range (2015-2020)
Figure 24. Global Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Figure 25. Global Recombinant Human Insulin Sales Market Share by Application in 2019
Figure 26. Global Recombinant Human Insulin Revenue Market Share by Application (2015-2020)
Figure 27. Global Recombinant Human Insulin Revenue Market Share by Application in 2019
Figure 28. North America Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 29. North America Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 31. North America Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 32. U.S. Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 33. U.S. Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 35. Canada Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Recombinant Human Insulin Market Share by Type in 2019
Figure 37. North America Recombinant Human Insulin Market Share by Application in 2019
Figure 38. Europe Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 39. Europe Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 41. Europe Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 42. Germany Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 43. Germany Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 45. France Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 47. U.K. Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 49. Italy Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 51. Russia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Recombinant Human Insulin Market Share by Type in 2019
Figure 53. Europe Recombinant Human Insulin Market Share by Application in 2019
Figure 54. Asia Pacific Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 55. Asia Pacific Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Recombinant Human Insulin Sales Market Share by Region in 2019
Figure 57. Asia Pacific Recombinant Human Insulin Revenue Market Share by Region in 2019
Figure 58. China Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 59. China Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 61. Japan Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 63. South Korea Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 65. India Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 67. Australia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 69. Taiwan Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 71. Indonesia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 73. Thailand Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 75. Malaysia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 77. Philippines Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 79. Vietnam Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Recombinant Human Insulin Market Share by Type in 2019
Figure 81. Asia Pacific Recombinant Human Insulin Market Share by Application in 2019
Figure 82. Latin America Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 83. Latin America Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 85. Latin America Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 86. Mexico Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 87. Mexico Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 89. Brazil Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 91. Argentina Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Recombinant Human Insulin Market Share by Type in 2019
Figure 93. Latin America Recombinant Human Insulin Market Share by Application in 2019
Figure 94. Middle East and Africa Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 95. Middle East and Africa Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 98. Turkey Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 99. Turkey Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 101. Saudi Arabia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 103. U.A.E Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Recombinant Human Insulin Market Share by Type in 2019
Figure 105. Middle East and Africa Recombinant Human Insulin Market Share by Application in 2019
Figure 106. Akron Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Dance Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Gan & Lee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dongbro Pharmaceuticri Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 114. North America Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 116. Europe Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 118. Asia Pacific Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 120. Latin America Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 122. Middle East and Africa Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
